Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
Completed · Phase 3
Conditions studied: Attention Deficit Disorder With Hyperactivity
In brief
This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
Key facts
- Study ID
- NCT00018863
- Run by
- New York State Psychiatric Institute
- People needed
- 165
- Starts
- 2001-04-01
- Expected to finish
- 2006-11-30
- Last updated by the study team
- 2020-12-02
Who can join
Age: 3 and older, up to 5. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, Irvine — Irvine, California, United States
- University of California, Los Angeles — Los Angeles, California, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- New York State Psychiatric Institute — New York, New York, United States
- New York University School of Medicine — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.